RELY Form 144: 12,000 shares ($285K) reported
RELY reports sale of common stock on Form 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RELY reports sale of common stock on Form 144. The filing lists 12,000 shares of Common Stock with an aggregate value of $285,000.00 associated with Morgan Stanley Smith Barney LLC on 05/14/2026. The filing also discloses multiple prior sales executed under a 10b5-1 sales plan, including 34,383 shares for $855,875.84 on 05/11/2026 and 29,049 shares for $522,425.93 on 03/04/2026.
Insights
Routine Form 144 sale reporting under a 10b5-1 plan; no allegations or novel disclosures.
The filing documents a registered sale of 12,000 shares valued at $285,000.00 and enumerates prior sales executed under a 10b5-1 sales plan. These entries identify transaction dates, share counts, and proceeds for each sale.
Because this is disclosure of secondary sales by an affiliate and includes multiple 10b5-1 transactions, the primary compliance items to note are the plan references and consistent reporting of sale dates and amounts. Subsequent filings will show any additional dispositions.
Key Figures
Key Terms
Form 144 regulatory
10b5-1 Sales Plan regulatory
Previously Exercised Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the RELY Form 144 report show?
Were prior sales disclosed for the reporting person in the RELY filing?
Who is listed as the broker or selling agent in the Form 144?
Do the sales appear to be part of a prearranged plan?
Does the Form 144 indicate who receives proceeds from these sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.